focus -WSS

focus

author：comprehensive 2025-08-24 23:27:50 - browse：46

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

WSS

A pediatrician calls for Congress to pass the child tax credit deal

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Fentanyl is making it harder to start addiction treatment

Fentanyl is making it harder to start addiction treatment

Liver decline slowed by off

Dog Aging Project founders on what lies ahead after losing funding

hotspot

focus

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

HPV vaccine, cervical cancer study delivers historic results

Peter Hotez and the public health issue of online harassment

Fentanyl is making it harder to start addiction treatment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Medical leaders decry Supreme Court decision on affirmative action

Prior authorization reform is both possible and imperative

Virginia high school admissions case could be legal follow

Prior authorization reform is both possible and imperative

explore

Study finds gene variants tied to breast cancer risk in Black women

Maisha Meds is a PBM, but don't call it that

Cardiologists urge adding sexual orientation, gender identity to health records

To bolster infectious disease surveillance, genomics powerhouses team up

Listen: A conversation with researcher Kevin Esvelt on biosecurity

To bolster infectious disease surveillance, genomics powerhouses team up

knowledge

explore

hotspot

hotspot